Expertise in
12
conditions

Dr. Thenappan Thenappan

Advanced Heart Failure and Transplant Cardiology | Cardiology
Fairview Express Care
717 Delaware St Se, Suite 340, 
Minneapolis, MN 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Expertise in
12
conditions
Fairview Express Care
717 Delaware St Se, Suite 340, 
Minneapolis, MN 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Thenappan Thenappan is an Advanced Heart Failure and Transplant Cardiologist and a Cardiologist in Minneapolis, Minnesota. Dr. Thenappan is highly rated in 12 conditions, according to our data. His top areas of expertise are Pulmonary Hypertension, Hypertension, Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Transplant, and Angioplasty. Dr. Thenappan is currently accepting new patients.

His clinical research consists of co-authoring 118 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Advanced Heart Failure and Transplant Cardiology
Cardiology
Licenses
Internal Medicine in MN
Hospital Affiliations
Essentia Health St Mary's Medical Center
M Health Fairview University Of Mn
M Health Fairview Woodwinds Hospital
M Health Fairview Ridges Hospital
M Health Fairview St John's Hospital
Languages Spoken
English
Tamil
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Sanford Health
  • HMO
  • PPO

Locations

FAIRVIEW EXPRESS CARE
717 Delaware St Se, Suite 340, Minneapolis, MN 55414
Other Locations
HEALTHEAST MEDICAL RESEARCH INSTITUTE
1700 University Ave W, 6th Floor W, Saint Paul, MN 55104
FAIRVIEW EXPRESS CARE
909 Fulton St Se, Suite 4 392, Minneapolis, MN 55455
FAIRVIEW EXPRESS CARE
500 Harvard St Se, Minneapolis, MN 55455
FAIRVIEW EXPRESS CARE
201 E Nicollet Blvd, Burnsville, MN 55337

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

An Early Feasibility Study Assessing Treatment of Pulmonary Hypertension Using the Aria CV Pulmonary Hypertension System
An Early Feasibility Study Assessing Treatment of Pulmonary Hypertension Using the Aria CV Pulmonary Hypertension System
Enrollment Status: Recruiting
Publish Date: January 29, 2025
Intervention Type: Device
Study Phase: Not Applicable
A Phase 2, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Sotatercept Versus Placebo for the Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension (Cpc-PH) Due to Heart Failure With Preserved Ejection Fraction (HFpEF)
A Phase 2, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Sotatercept Versus Placebo for the Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension (Cpc-PH) Due to Heart Failure With Preserved Ejection Fraction (HFpEF)
Enrollment Status: Active_not_recruiting
Publish Date: March 20, 2025
Intervention Type: Drug
Study Drug: Sotatercept
Study Phase: Phase 2
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
Enrollment Status: Terminated
Publish Date: November 24, 2023
Intervention Type: Drug
Study Drug: Inhaled treprostinil solution
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
Enrollment Status: Completed
Publish Date: July 27, 2022
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
Enrollment Status: Terminated
Publish Date: November 10, 2020
Intervention Type: Drug
Study Phase: Phase 3
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
Enrollment Status: Terminated
Publish Date: October 22, 2020
Intervention Type: Drug
Study Phase: Phase 3
Beta-blockers in Pulmonary Arterial Hypertension - A Phase 2 Double-Blind, Placebo-Controlled, Crossover Study Evaluating the Efficacy, and Safety of Carvedilol for Right Ventricular Dysfunction in Pulmonary Arterial Hypertension
Beta-blockers in Pulmonary Arterial Hypertension - A Phase 2 Double-Blind, Placebo-Controlled, Crossover Study Evaluating the Efficacy, and Safety of Carvedilol for Right Ventricular Dysfunction in Pulmonary Arterial Hypertension
Enrollment Status: Terminated
Publish Date: June 16, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 6 Less Clinical Trials

118 Total Publications

Lactobacillus Restructures the Micro/Mycobiome to Combat Inflammation-Mediated Right Ventricular Dysfunction in Pulmonary Arterial Hypertension.
Lactobacillus Restructures the Micro/Mycobiome to Combat Inflammation-Mediated Right Ventricular Dysfunction in Pulmonary Arterial Hypertension.
Journal: Circulation. Heart failure
Published: May 16, 2025
Similar Doctors
Nicholas A. Haglund
Expertise in
9
conditions
Dr. Nicholas A. Haglund
Cardiology | Advanced Heart Failure and Transplant Cardiology
Expertise in
9
conditions
Dr. Nicholas A. Haglund
Cardiology | Advanced Heart Failure and Transplant Cardiology

Allina Health System

800 E 28th St, 
Minneapolis, MN 
 (2.2 mi)
612-262-8425
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Nicholas Haglund is a Cardiologist and an Advanced Heart Failure and Transplant Cardiologist in Minneapolis, Minnesota. Dr. Haglund is highly rated in 9 conditions, according to our data. His top areas of expertise are Heart Failure, Pulmonary Edema, Cardiogenic Shock, Heart Transplant, and Endoscopy. Dr. Haglund is currently accepting new patients.

Expertise in
14
conditions
Dr. Michael A. Samara
Advanced Heart Failure and Transplant Cardiology | Cardiology
Expertise in
14
conditions
Dr. Michael A. Samara
Advanced Heart Failure and Transplant Cardiology | Cardiology

Allina Health System

1455 Saint Francis Ave, 
Shakopee, MN 
 (19.3 mi)
651-635-9173
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Michael Samara is an Advanced Heart Failure and Transplant Cardiologist and a Cardiologist in Shakopee, Minnesota. Dr. Samara is highly rated in 14 conditions, according to our data. His top areas of expertise are Heart Failure, Pulmonary Edema, Cardiomyopathy, Cardiac Ablation, and Endoscopy. Dr. Samara is currently accepting new patients.

Expertise in
10
conditions
Dr. Mosi K. Bennett
Cardiology | Advanced Heart Failure and Transplant Cardiology
Expertise in
10
conditions
Dr. Mosi K. Bennett
Cardiology | Advanced Heart Failure and Transplant Cardiology

Allina Health System

1455 Saint Francis Ave, Suite 1000, 
Shakopee, MN 
 (19.3 mi)
952-428-2099
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Mosi Bennett is a Cardiologist and an Advanced Heart Failure and Transplant Cardiologist in Shakopee, Minnesota. Dr. Bennett is highly rated in 10 conditions, according to our data. His top areas of expertise are Heart Failure, Pulmonary Edema, Heart Failure with Preserved Ejection Fraction (HFpEF), Cardiomyopathy, and Heart Transplant. Dr. Bennett is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Thenappan's expertise for a condition
ConditionClose
View All 31 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile